Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Problems related to antifungal prescription: a qualitative study of the views of intensivists.

Salci TP, Batilana AP, Pietrobon R, Caparroz-Assef SM.

J Eval Clin Pract. 2014 Aug;20(4):460-6. doi: 10.1111/jep.12181. Epub 2014 May 20.

PMID:
24840772
4.

Discordance between perception and treatment practices associated with intensive care unit-acquired bacteriuria and funguria: a Canadian physician survey.

Chant C, Dos Santos CC, Saccucci P, Smith OM, Marshall JC, Friedrich JO.

Crit Care Med. 2008 Apr;36(4):1158-67. doi: 10.1097/CCM.0b013e3181692af9.

PMID:
18379242
5.
6.

Documentation of best interest by intensivists: a retrospective study in an Ontario critical care unit.

Ratnapalan M, Cooper AB, Scales DC, Pinto R.

BMC Med Ethics. 2010 Feb 10;11:1. doi: 10.1186/1472-6939-11-1.

7.

Facilitating clinician adherence to guidelines in the intensive care unit: A multicenter, qualitative study.

Sinuff T, Cook D, Giacomini M, Heyland D, Dodek P.

Crit Care Med. 2007 Sep;35(9):2083-9.

PMID:
17855822
8.

[Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].

Alvarez-Lerma F, Nolla J, Palomar M, León MA.

Enferm Infecc Microbiol Clin. 2003 Feb;21(2):83-8. Spanish.

PMID:
12586031
9.

Factors that contribute to physician variability in decisions to limit life support in the ICU: a qualitative study.

Wilson ME, Rhudy LM, Ballinger BA, Tescher AN, Pickering BW, Gajic O.

Intensive Care Med. 2013 Jun;39(6):1009-18. doi: 10.1007/s00134-013-2896-x. Epub 2013 Apr 5.

PMID:
23559079
10.

Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.

Garey KW, Neuhauser MM, Bearden DT, Cannon JP, Lewis RE, Gentry LO, Kontoyiannis DP.

Mycoses. 2006 May;49(3):226-31.

PMID:
16681815
11.
12.
13.

Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study.

Watkins C, Timm A, Gooberman-Hill R, Harvey I, Haines A, Donovan J.

Fam Pract. 2004 Dec;21(6):661-9. Epub 2004 Nov 4.

PMID:
15528289
14.

General practitioners' views and experiences of counselling for physical activity through the New Zealand Green Prescription program.

Patel A, Schofield GM, Kolt GS, Keogh JW.

BMC Fam Pract. 2011 Nov 2;12:119. doi: 10.1186/1471-2296-12-119.

16.

Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients.

Mehta S, Burry L, Fischer S, Martinez-Motta JC, Hallett D, Bowman D, Wong C, Meade MO, Stewart TE, Cook DJ; Canadian Critical Care Trials Group..

Crit Care Med. 2006 Feb;34(2):374-80.

PMID:
16424717
17.

Oncologists and primary care physicians' attitudes toward pain control and morphine prescribing in France.

Larue F, Colleau SM, Fontaine A, Brasseur L.

Cancer. 1995 Dec 1;76(11):2375-82.

18.

Initiating inhaled steroid treatment for children with asthma in the emergency room: current reported prescribing rates and frequently cited barriers.

Andrews AL, Teufel RJ 2nd, Basco WT Jr.

Pediatr Emerg Care. 2013 Sep;29(9):957-62. doi: 10.1097/PEC.0b013e3182a219d0.

PMID:
23974712
19.

Secondary care doctors' perception of appropriate prescribing.

Ljungberg C, Lindblad AK, Tully M.

J Eval Clin Pract. 2009 Feb;15(1):110-5. doi: 10.1111/j.1365-2753.2008.00963.x.

PMID:
19239590
20.

Doctors' beliefs and knowledge on corticosteroid-induced osteoporosis: identifying barriers to improve prevention.

Duyvendak M, Naunton M, van Roon EN, Brouwers JR.

J Clin Pharm Ther. 2011 Jun;36(3):356-66. doi: 10.1111/j.1365-2710.2010.01185.x. Epub 2010 Oct 19.

PMID:
21545615

Supplemental Content

Support Center